Link between macrophage migration inhibitory factor and cellular redox regulation

Antioxidants and Redox Signaling

Volumn 7, Issue 9-10, 2005, Pages 1234-1248

  Thiele, Michael ^a   Bernhagen, Jürgen ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CYSTEINE; LEUCINE; MACROPHAGE MIGRATION INHIBITION FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN; PROTEIN DISULFIDE REDUCTASE (GLUTATHIONE); PROTEIN TRX; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; APOPTOSIS; CATALYSIS; CELL ACTIVITY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; EVOLUTION; HOMEOSTASIS; HUMAN; IMMUNITY; IN VITRO STUDY; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE MIGRATION; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN MOTIF; REVIEW; STRUCTURAL HOMOLOGY; STRUCTURE ACTIVITY RELATION;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; BINDING SITES; CATALYSIS; CYTOKINES; DISULFIDES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MACROPHAGES; MICE; MODELS, BIOLOGICAL; MONOCYTES; OXIDATION-REDUCTION; OXIDOREDUCTASES; PEPTIDES; PROTEIN DISULFIDE REDUCTASE (GLUTATHIONE); SEQUENCE HOMOLOGY, AMINO ACID; STRUCTURE-ACTIVITY RELATIONSHIP; THIOREDOXIN;

EID: 24144433455     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2005.7.1234     Document Type: Review

References (154)

1. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV, and Neckers LM. Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature 392: 405-408, 1998.
2. Andoh T, Chock PB, and Chiueh CC. The roles of thioredoxin in protection against oxidative stress-induced apoptosis in SH-SY5Y cells. J Biol Chem 277: 9655-9660, 2002.
3. Aslund F, Berndt KD, and Holmgren A. Redox potentials of glutaredoxins and other thiol-disulfide oxidoreductases of the thioredoxin superfamily determined by direct protein-protein redox equilibria. J Biol Chem 272: 30780-30786, 1997.
4. Baker A, Payne CM, Briehl MM, and Powis G. Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivo. Cancer Res 57: 5162-5167, 1997.
5. Bast A and Haenen GR. Interplay between lipoic acid and glutathione in the protection against microsomal lipid peroxidation. Biochim Biophys Acta 963: 558-561, 1988.
6. Bech-Otschir D, Kraft R, Huang X, Henklein P, Kapelari B, Pollmann C, and Dubiel W. COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J 20: 1630-1639, 2001.
7. Bech-Otschir D, Seeger M, and Dubiel W. The COP9 signalosome: at the interface between signal transduction and ubiquitin-dependent proteolysis. J Cell Sci 115: 467-473, 2002.
8. Bendrat K, Alabed Y, Callaway DJE, Peng T, Calandra T, Metz CN, and Bucala R. Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor. Biochemistry 36: 15356-15362, 1997.
9. Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W, Manogue KR, Cerami A, and Bucala R. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365: 756-759, 1993.
10. Bernhagen J, Mitchell RA, Calandra T, Voelter W, Cerami A, and Bucala R. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 33: 14144-14155, 1994.
11. Bernhagen J, Kapurniotu A, Frank RW, Flieger O, Bucala R, and Brunner H. Enzymatic oxidoreductase activity of the cytokine MIF. Eur Cytokine Netw 1: A453 (585), 1996.
12. Bernhagen J, Calandra T, and Bucala R. Regulation of the immune response by macrophage migration inhibitory factor: biological and structural features. J Mol Med 76: 151-161, 1998.
13. Berse M, Bounpheng M, Huang X, Christy B, Pollmann C, and Dubiel W. Ubiquitin-dependent degradation of Id1 and Id3 is mediated by the COP9 signalosome. J Mol Biol 343: 361-370, 2004.
14. Bianchi E, Denti S, Granata A, Bossi G, Geginat J, Villa A, Rogge L and Pardi R. Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity. Nature 404: 617-621, 2000.
15. Bishopric NH, and Webster KA. Preventing apoptosis with thioredoxin: ASK me how. Circ Res 90: 1237-1239, 2002.
16. Bloom B and Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153: 80-82, 1966.
17. Bucala R. MIF rediscovered-cytokine, pituitary hormone, and glucocorticoid-induced regulator of the immune response. FASEB J 10: 1607-1613, 1996.
18. Bucala R. Neuroimmunomodulation by macrophage migration inhibitory factor (MIF). Ann NY Acad Sci 840: 74-82, 1998.
19. Cabrele C, Flori S, Pegoraro S, and Moroder L. Redox-active cyclic bis(cysteinyl)peptides as catalysts for in vitro oxidative protein folding. Chem Biol 9: 731-740, 2002.
20. Calandra T. Macrophage migration inhibitory factor and host innate immune responses to microbes. Scand J Infect Dis 35: 573-576, 2003.
21. Calandra T and Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3: 791-800, 2003.
22. Calandra T, Bernhagen J, Mitchell RA, and Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 179: 1895-1902, 1994.
23. Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, Cerami A, and Bucala R. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377: 68-71, 1995.
24. Calmels S, Hainaut P, and Ohshima H. Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein. Cancer Res 57: 3365-3369, 1997.
25. Carmody RJ and Cotter TG. Signalling apoptosis: a radical approach. Redox Rep 6: 77-90, 2001.
26. Chamovitz DA and Segal D. JAB1/CSN5 and the COP9 signalosome. A complex situation. EMBO Rep 2: 96-101, 2001.
27. Chen X, Li Y, Wei K, Li L, Liu W, Zhu Y, Qiu Z, and He F. The potentiation role of hepatopoietin on activator protein-1 is dependent on its sulfhydryl oxidase activity. J Biol Chem 278: 49022-49030, 2003.
28. Claret FX, Hibi M, Dhut S, Toda T, and Karin M. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature 383: 453-457, 1996.
29. Cope GA, Suh GS, Aravind L, Schwarz SE, Zipursky SL, Koonin EV, and Deshaies RJ. Role of predicted metalloprotease motif of Jab1/Csn5 in cleavage of Nedd8 from Cull. Science 298: 608-611, 2002.
30. Das UN. Current advances in sepsis and septic shock with particular emphasis on the role of insulin. Med Sci Monit 9: RA181-RA192, 2003.
31. David JR. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci U S A 56: 72-77, 1966.
32. David JR, Al-Askari S, Lawrence HS, and Thomas L. Antigens can stimulate sensitized lymphocytes in culture to produce macrophage migration inhibitory factors. J Immunol 93: 264-273, 1964.
33. Delphin C, Cahen P, Lawrence JJ, and Baudier J. Characterization of baculovirus recombinant wild-type p53. Dimerization of p53 is required for high-affinity DNA binding and cysteine oxidation inhibits p53 DNA binding. Eur J Biochem 223: 683-692, 1994.
34. Donn RP and Ray DW. Macrophage migration inhibitory factor: molecular, cellular and genetic aspects of a key neuroendocrine molecule. J Endocrinol 182: 1-9, 2004.
35. Donnelly SC and Bucala R. Macrophage migration inhibitory factor: a regulator of glucocorticoid activity with a critical role in inflammatory desease. Mol Med Today 3: 502-507, 1998.
36. Donnelly SC, Haslett C, Reid PT, Grant IS, Wallace WA, Metz CN, Bruce LJ, and Bucala R. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 3: 320-323, 1997.
37. Eguchi M, McMillan M, Nguyen C, Teo JL, Chi EY, Henderson WR Jr, and Kahn M. Chemogenomics with peptide secondary structure mimetics. Comb Chem High Throughput Screen 6: 611-621, 2003.
38. Eickhoff R, Baldauf C, Koyro HW, Wennemuth G, Suga Y, Seitz J, Henkel R, and Meinhardt A. Influence of macrophage migration inhibitory factor (MIF) on the zinc content and redox state of protein-bound sulphydryl groups in rat sperm: indications for a new role of MIF in sperm maturation. Mol Hum Reprod 10: 605-611, 2004.
39. Ellis LBM, Saurugger P, and Woodward C. Identification of the three-dimensional thioredoxin motif: related structure in the ORF3 protein of the Staphylococcus aureus mer operon. Biochemistry 31: 4882-4891, 1992.
40. Fernandes AP and Holmgren A. Glutaredoxins: glutathione-dependent redox enzymes with functions far beyond a simple thioredoxin backup system. Antioxid Redox Signal 6: 63-74, 2004.
41. Flieger O, Engling A, Bucala R, Lue H, Nickel W, and Bernhagen J. Regulated secretion of macrophage migration inhibitory factor is mediated by a non-classical pathway involving an ABC transporter. FEBS Lett 551: 78-86, 2003.
42. Flohe L, Budde H, and Hofmann B. Peroxiredoxins in antioxidant defense and redox regulation. Biofactors 19: 3-10, 2003.
43. Flohe L, Jaeger T, Pilawa S, and Sztajer H. Thiol-dependent peroxidases care little about homology-based assignments of function. Redox Rep 8: 256-264, 2003.
44. Freedman RB, Hirst TR, and Tuite MF. Protein disulphide isomerase: building bridges in protein folding. Trends Biochem Sci 19: 331-336, 1994.
45. Freedman RB, Klappa P, and Ruddock LW. Protein disulfide isomerases exploit synergy between catalytic and specific binding domains. EMBO Rep 3: 136-140, 2002.
46. Freemerman AJ and Powis G. A redox-inactive thioredoxin reduces growth and enhances apoptosis in WEHI7.2 cells. Biochem Biophys Res Commun 274: 136-141, 2000.
47. Fukuzawa J, Nishihira J, Hasebe N, Haneda T, Osaki J, Saito T, Nomura T, Fujino T, Wakamiya N, and Kikuchi K. Contribution of macrophage migration inhibitory factor to extracellular signal-regulated kinase activation by oxidative stress in cardiomyocytes. J Biol Chem 277: 24889-24895, 2002.
48. Galat A, Riviere S, Bouet F, and Menez A. A diversified family of 12-kDa proteins with a high amino acid sequence similarity to macrophage migration-inhibitory factor (MIF). Eur J Biochem 224: 417-421, 1994.
49. George M and Vaughan JH. Migration of mononuclear cells in capillary tubes. Proc Soc Exp Biol Med 111: 514-521, 1962.
50. Ghezzi P, Bernhagen J, Bizzarri C, Sergi R, Caselli G, Kleemann R, and Bertini R. In: The Immune Consequences of Trauma, Shock and Sepsis-Mechanisms and Therapeutic Approaches, edited by Faist E, Baue AE, and Schildberg FW. Munich: Pabst Science Publishers, 2000.
51. Graeber TG, Peterson JF, Tsai M, Monica K, Fornace AJ Jr, and Giaccia AJ. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol Cell Biol 14:6264-6277, 1994.
52. Gregersen PK and Bucala R. Macrophage migration inhibitory factor, MIF alleles, and the genetics of inflammatory disorders: incorporating disease outcome into the definition of phenotype. Arthritis Rheum 48: 1171-1176, 2003.
53. Haendeler J, Hoffmann J, Tischler V, Berk BC, Zeiher AM, and Dimmeler S. Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69. Nat Cell Biol 4: 743-749, 2002.
54. Haendeler J, Tischler V, Hoffmann J, Zeiher AM, and Dimmeler S. Low doses of reactive oxygen species protect endothelial cells from apoptosis by increasing thioredoxin-1 expression. FEBS Lett 577: 427-433, 2004.
55. Haenen GRMM and Bast A. Scavenging of hypochlorous acid by lipoic acid. Biochem Pharmacol 42: 2244-2246, 1991.
56. Hainaut P and Mann K. Zinc binding and redox control of p53 structure and function. Antioxid Redox Signal 3: 611-623, 2001.
57. Hainaut P and Milner J. A structural role for metal ions in the "wild-type" conformation of the tumor suppressor protein p53. Cancer Res 53: 1739-1742, 1993.
58. Hainaut P and Milner J. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res 53: 4469-4473, 1993.
59. Hainaut P, Rolley N, Davies M, and Milner J. Modulation by copper of p53 conformation and sequence-specific DNA binding: role for Cu(II)/Cu(I) redox mechanism. Oncogene 10: 27-32, 1995.
60. Harari-Steinberg O and Chamovitz DA. The COP9 signalosome: mediating between kinase signaling and protein degradation. Curr Protein Pept Sci 5: 185-189, 2004.
61. Hermanowski-Vosatka A, Mundt SS, Ayala JM, Goyal S, Hanlon WA, Czerwinski RM, Wright SD, and Whitman CP. Enzymatically inactive macrophage migration inhibitory factor inhibits monocyte chemotaxis and random migration. Biochemistry 38: 12841-12849, 1999.
62. Hirota K, Matsui M, Iwata S, Nishiyama A, Mori K and Yodoi J. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc Natl Acad Sci U S A 94: 3633-3638, 1997.
63. Hirota K, Nakamura H, Masutani H, and Yodoi J. Thioredoxin superfamily and thioredoxin-inducing agents. Ann N Y Acad Sci 957: 189-199, 2002.
64. Hofmann B, Hecht HJ, and Flohe L. Peroxiredoxins. Biol Chem 383: 347-364, 2002.
65. Holmgren A. Glutathione-dependent synthesis of deoxyribonucleotides- purification and characterization of glutaredoxin from Eschericha coli. J Biol Chem 254: 3664-3671, 1979.
66. Holmgren A. Glutathione-dependent synthesis of deoxyribonucleotides- characterization of the enzymatic mechanism of Escherichia coli glutaredoxin. J Biol Chem 254: 3672-3678, 1979.
67. Holmgren A. Thioredoxin catalyses the reduction of insulin disulfides by dithiothreitol and dihydrolipoamide. J Biol Chem 254: 9627-9632, 1979.
68. Holmgren A. Glutaredoxin from Escherichia coli and calf thymus. Methods Enzymol 113: 525-528, 1985.
69. Holmgren A. Thioredoxin. Annu Rev Biochem 54: 237-271, 1985.
70. Hudson JD, Shoaibi MA, Maestro R, Carnero A, Hannon GJ, and Beach DH. A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med 190: 1375-1382, 1999.
71. Hwang CY, Ryu YS, Chung MS, Kim KD, Park SS, Chae SK, Chae HZ, and Kwon KS. Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1. Oncogene 23: 8868-8875, 2004.
72. Iwata S, Hori T, Sato N, Hirota K, Sasada T, Mitsui A, Hirakawa T, and Yodoi J. Adult T cell leukemia (ATL)-derived factor/human thioredoxin-prevents apoptosis of lymphoid cells induced by L-cystine and glutathione depletion: possible involvement of thiol-mediated redox regulation in apoptosis caused by pro-oxidant state. J Immunol 158: 3108-3117, 1997.
73. Jayaraman L, Murthy KG, Zhu C, Curran T, Xanthoudakis S, and Prives C. Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev 11: 558-570, 1997.
74. Jones DP, Go YM, Anderson CL, Ziegler TR, Kinkade JM Jr, and Kirlin WG. Cysteine/cystine couple is a newly recognized node in the circuitry for biologic redox signaling and control. FASEB J 18: 1246-1248, 2004.
75. Jung H, Kim T, Chae HZ, Kim KT, and Ha H. Regulation of macrophage migration inhibitory factor and thiol-specific antioxidant protein PAG by direct interaction. J Biol Chem 276: 15504-15510, 2001.
76. Kagan VE, Shvedova A, Serbinova E, Khan S, Swanson C, Powell R, and Packer L. Dihydrolipoic acid-a universal antioxidant both in the membrane and in the aqueous phase. Reduction of peroxyl, ascorbyl and chromanoxyl radicals. Biochem Pharmacol 44: 1637-1649, 1992.
77. Kleemann R, Kapurniotu A, Frank RW, Gessner A, Mischke R, Flieger O, Jüttner S, Brunner H, and Bernhagen J. Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as a thiol-protein oxidoreductase. J Mol Biol 280: 85-102, 1998.
78. Kleemann R, Mischke R, Kapurniotu A, Brunner H, and Bernhagen J. Specific reduction of insulin disulfides by macrophage migration inhibitory factor (MIF) with glutathione and dihydrolipoamide: potential role in cellular redox processes. FEBS Lett 430: 191-196, 1998.
79. Kleemann R, Kapurniotu A, Mischke R, Held J, and Bernhagen J. Characterization of catalytic center mutants of macrophage migration inhibitory factor (MIF) and comparison with C81S MIF. Eur J Biochem 261: 753-766, 1999.
80. Kleemann R, Hausser A, Geiger G, Mischke R, Burger-Kentischer A, Flieger O, Johannes FJ, Roger T, Calandra T, Kapurniotu A, Grell M, Finkelmeier D, Brunner H, and Bernhagen J. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 408: 211-216, 2000.
81. Kondo N, Ishii Y, Kwon YW, Tanito M, Horita H, Nishinaka Y, Nakamura H, and Yodoi J. Redox-sensing release of human thioredoxin from T lymphocytes with negative feedback loops. J Immunol 172: 442-448, 2004.
82. Kondo N, Ishii Y, Son A, Sakakura-Nishiyama J, Kwon YW, Tanito M, Nishinaka Y, Matsuo Y, Nakayama T, Taniguchi M, and Yodoi J. Cysteine-dependent immune regulation by TRX and MIF/GIF family proteins. Immunol Lett 92: 143-147, 2004.
83. Kotake S, Kitaichi N, and Ohno S. Macrophage migration inhibitory factor in uveitis. Int Ophthalmol Clin 42: 99-103, 2002.
84. Kwon YW, Masutani H, Nakamura H, Ishii Y, and Yodoi J. Redox regulation of cell growth and cell death. Biol Chem 384: 991-996, 2003.
85. Leng L, Metz CN, Fang YXJ, Donnelly S, Baugh J, Delohery T, Chen Y, Mitchell RA, and Bucala R. MIF signal transduction initiated by binding to CD74. J Exp Med 197: 1467-1476, 2003.
86. Li Y, Lu C, Xing G, Zhu Y, and He F. Macrophage migration inhibitory factor directly interacts with hepatopoietin and regulates the proliferation of hepatoma cell. Exp Cell Res 300: 379-387, 2004.
87. Liu Y and Min W. Thioredoxin promotes ASK1 ubiquitination and degradation to inhibit ASK1-mediated apoptosis in a redox activity-independent manner. Circ Res 90: 1259-1266, 2002.
88. Lolis E. Glucocorticoid counter regulation: macrophage migration inhibitory factor as a target for drug discovery. Curr Opin Pharmacol 1: 662-668, 2001.
89. Lolis E and Bucala R. Crystal structure of macrophage migration inhibitory factor (MIF), a glucocorticoid-induced regulator of cytokine production, reveals a unique architecture. Proc Assoc Am Physicians 108: 415-419, 1996.
90. Lu C, Li Y, Zhao Y, Xing G, Tang F, Wang Q, Sun Y, Wei H, Yang X, Wu C, Chen J, Guan KL, Zhang C, Chen H, and He F. Intracrine hepatopoietin potentiates AP-1 activity through JAB1 independent of MAPK pathway. FASEB J 16:90-92, 2002.
91. Lubetsky JB, Swope M, Dealwis C, Blake P, and Lolis E. Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity. Biochemistry 38: 7346-7354, 1999.
92. Lue H, Kleemann R, Calandra T, Roger T, and Bernhagen J. Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microbes Infect 4: 449-460, 2002.
93. Lundstrom-Ljung J and Holmgren A. Glutaredoxin accelerates glutathione-dependent folding of reduced ribonuclease A together with protein disulfide-isomerase. J Biol Chem 270: 7822-7828, 1995.
94. Lyapina S, Cope G, Shevchenko A, Serino G, Tsuge T, Zhou C, Wolf DA, Wei N, and Deshaies RJ. Promotion of NEDD-CUL1 conjugate cleavage by COP9 signalosome. Science 292: 1382-1385, 2001.
95. Merwin JR, Mustacich DJ, Muller EG, Pearson GD, and Merrill GF. Reporter gene transactivation by human p53 is inhibited in thioredoxin reductase null yeast by a mechanism associated with thioredoxin oxidation and independent of changes in the redox state of glutathione. Carcinogenesis 23: 1609-1615, 2002.
96. Mischke R, Kleemann R, Brunner H, and Bernhagen J. Cross-linking and mutational analysis of the oligomerization state of the cytokine macrophage migration inhibitory factor (MIF). FEBS Lett 427: 85-90, 1998.
97. Mitchell RA and Bucala R. Tumor growth-promoting properties of macrophage migration inhibitory factor. Semin Cancer Biol 10: 359-366, 2000.
98. Mitchell RA, Liao H, Chesney J, Fingerle-Rowson G, Baugh J, David J, and Bucala R. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci USA 99: 345-350, 2002.
99. Mühlhahn P, Bernhagen J, Czisch M, Georgescu J, Renner C, Ross A, Bucala R, and Holak TA. NMR characterization of structure, backbone dynamics and glutathione binding of the human macrophage migration inhibitory factor (MIF). Protein Sci 5: 2095-2103, 1996.
100. Naumann M, Bech-Otschir D, Huang X, Ferrell K, and Dubiel W. COP9 signalosome-directed c-Jun activation/stabilization is independent of JNK. J Biol Chem 274: 35297-35300, 1999.
101. Nguyen MT, Lue H, Kleemann R, Thiele M, Tolle G, Finkelmeier D, Wagner E, Braun A, and Bernhagen J. The cytokine macrophage migration inhibitory factor (MIF) reduces pro-oxidative stress-induced apoptosis. J Immunol 170: 3337-3347, 2003.
102. Nguyen MT, Beck J, Lue H, Fünfzig H, Kleemann R, Koolwijk P, Kapurniotu A, and Bernhagen J. A sixteen residue peptide fragment of macrophage migration inhibitory factor, MIF(50-65), exhibits redox activity and has MIF-like biological functions. J Biol Chem 278: 33654-33671, 2003.
103. Nilsson J, Soderberg O, Nilsson K, and Rosen A. Thioredoxin prolongs survival of B-type chronic lymphocytic leukemia cells. Blood 95: 1420-1426, 2000.
104. Nishihira J, Ishibashi T, Fukushima T, Sun B, Sato Y, and Todo S. Macrophage migration inhibitory factor (MIF): its potential role in tumor growth and tumor-associated angiogenesis. Ann N Y Acad Sci 995: 171-182, 2003.
105. Orita M, Yamamoto S, Katayama N, and Fujita S. Macrophage migration inhibitory factor and the discovery of tautomerase inhibitors. Curr Pharm Des 8: 1297-1317, 2002.
106. Pearson GD and Merrill GF. Deletion of the Saccharomyces cerevisiae TRR1 gene encoding thioredoxin reductase inhibits p53-dependent reporter gene expression. J Biol Chem 273: 5431-5434, 1998.
107. Pekkari K and Holmgren A. Truncated thioredoxin: physiological functions and mechanism. Antioxid Redox Signal 6: 53-61, 2004.
108. Pekkari K, Gurunath R, Arner ES, and Holmgren A. Truncated thioredoxin is a mitogenic cytokine for resting human peripheral blood mononuclear cells and is present in human plasma. J Biol Chem 275: 37474-37480, 2000.
109. Potolicchio I, Santambrogio L, and Strominger JL. Molecular interaction and enzymatic activity of macrophage migration inhibitory factor (MIF) with immunorelevant peptides. J Biol Chem 278: 30889-30895, 2003.
110. Powis G, Mustacich D, and Coon A. The role of the redox protein thioredoxin in cell growth and cancer. Free Radic Biol Med 29: 312-322, 2000.
111. Rainwater R, Parks D, anderson ME, Tegtmeyer P, and Mann K. Role of cysteine residues in regulation of p53 function. Mol Cell Biol 15: 3892-3893, 1995.
112. Rhee SG, Kang SW, Netto LE, Seo MS, and Stadtman ER. A family of novel peroxidases, peroxiredoxins. Biofactors 10: 207-209, 1999.
113. Roger T, David J, Glauser M, and Calandra T. MIF regulates innate immune responses through modulation of Toll-like receptor-4. Nature 414: 920-924, 2001.
114. Rosengren E, Bucala R, Åman P, Jacobsson L, Odh G, Metz CN, and Rorsman H. The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction. Mol Med 2: 143-149, 1996.
115. Rosengren E, Aman P, Thelin S, Hansson C, Ahlfors S, Björk P, Jacobsson L, and Rorsman H. The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase. FEBS Lett 417: 85-88, 1997.
116. Rouhier N, Gelhaye E, and Jacquot JP. Glutaredoxin-dependent peroxiredoxin from poplar: protein-protein interaction and catalytic mechanism. J Biol Chem 277: 13609-13614, 2002.
117. Rubartelli A, Bajetto A, Allavena G, Wollman E, and Sitia R. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J Biol Chem 267: 24161-24164, 1992.
118. Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, and Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 17: 2596-2606, 1998.
119. Sakamoto W, Nishihira J, Fujie K, Handa H, Ozaki M, and Yukawa S. Inhibition of macrophage migration inhibitory factor secretion from macrophages by vitamin E. Biochim Biophys Acta 1404: 427-434, 1998.
120. Saluja AK and Bhagat L. Pancreatitis and associated lung injury: when MIF miffs. Gastroenterology 124: 844-847, 2003.
121. Sato N, Iwata S, Nakamura K, Hori T, Mori K, and Yodoi J. Thiol-mediated redox regulation of apoptosis. Possible roles of cellular thiols other than glutathione in T cell apoptosis. J Immunol 154: 3194-3203, 1995.
122. Scholich H, Murphy ME, and Sies H. Antioxidant activity of dihydrolipoate against microsomal lipid peroxidation and its dependence on alpha-tocopherol. Biochim Biophys Acta 1001: 256-261, 1989.
123. Seeger M, Kraft R, Ferrell K, Bech-Otschir D, B-O, Dumdey R, Schade R, Gordon C, Naumann M, and Dubiel W. A novel protein complex involved in signal transduction possessing similarities to 26S proteasome subunits. FASEB J 12: 469-478, 1998.
124. Shi T, Spain SM, and Rabenstein DL. Unexpectedly fast cis/trans isomerization of Xaa-Pro peptide bonds in disulfide-constrained cyclic peptides. J Am Chem Soc 126: 790-796, 2004.
125. Siedler F, Rudolph-Böhner S, Doi M, Musiol HJ, and Moroder L. Redox potentials of active-site bis(cysteinyl) fragments of thiol-protein oxidoreductases. Biochemistry 32: 7488-7495, 1993.
126. Siedler F, Quarzago D, Rudolph-Bohner S, and Moroder L. Redox-active bis-cysteinyl peptides. II. Comparative study on the sequence-dependent tendency for disulfide loop formation. Biopolymers 34: 1563-1572, 1994.
127. Smith JA and Pease LG. Reverse turns in peptides and proteins. CRC Crit Rev Biochem 8: 315-399, 1980.
128. Stamps SL, Fitzgerald MC, and Whitman CP. Characterization of the role of the amino-terminal proline in the enzymatic activity catalyzed by macrophage migration inhibitory factor. Biochemistry 37: 10195-10202, 1998.
129. Sugimoto H, Suzuki M, Nakagawa A, Tanaka I, and Nishihira J. Crystal structure of macrophage migration inhibitory factor from human lymphocyte at 2.1 Å resolution. FEBS Lett 389: 145-148, 1996.
130. Sugimoto H, Taniguchi M, Nakagawa A, Tanaka I, Suzuki M, and Nishihira J. Crystal structure of human D-dopachrome tautomerase, a homologue of macrophage migration inhibitory factor, at 1.54 angstrom resolution. Biochemistry 38: 3268-3279, 1999.
131. Sun C, Li H, Leng L, Raizada MK, Bucala R, and Sumners C. Macrophage migration inhibitory factor: an intracellular inhibitor of angiotensin II-induced increases in neuronal activity. J Neurosci 24: 9944-9952, 2004.
132. Sun H, Bernhagen J, Bucala R, and Lolis E. Crystal structure at 2.6 Å resolution of human macrophage migration inhibitory factor. Proc Natl Acad Sci USA 93: 5191-5196, 1996.
133. Suzuki M, Sugimoto H, Nakagawa A, Tanaka I, Nishihira J, and Sakai M. Crystal structure of the macrophage migration inibitory factor from rat liver. Nature Struct Biol 3: 259-266, 1996.
134. Swope M, Sun H-W, Blake PR, and Lolis E. Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor. EMBO J 1: 3534-3541, 1998.
135. Tagaya Y, Maeda Y, Mitsui A, Kondo, Matsui H, Hamuro J, Brown R, Arai K, Yokota T, Wakasugi N, and Yodoi J. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J 8: 757-764, 1989.
136. Tanaka T, Hosoi F, Yamaguchi-Iwai Y, Nakamura H, Masutani H, Ueda S, Nishiyama A, Takeda S, Wada H, Spyrou G, and Yodoi J. Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis. EMBO J 21: 1695-1703, 2002.
137. Taylor AB, Johnson WH Jr, Czerwinski RM, Li HS, Hackert ML, and Whitman CP. Crystal structure of macrophage migration inhibitory factor complexed with (E)-2-fluoro-p-hydroxycinnamate at 1.8 ÅA resolution: implications for enzymatic catalysis and inhibition. Biochemistry 38: 7444-7452, 1999.
138. Kip1 is instigated by Jab1. Nature 398: 160-164, 1999.
139. Tomoda K, Kato JY, Tatsumi E, Takahashi T, Matsuo Y, and Yoneda-Kato N. The Jab1/COP9 signalosome subcomplex is a downstream mediator of Bcr-Abl kinase activity and facilitates cell-cycle progression. Blood, 105: 775-783, 2005.
140. Tomura T, Watarai H, Honma N, Sato M, Iwamatsu A, Kato Y, Kuroki R, Nakano T, Mikayama T, and Ishizaka K. Immunosuppressive activities of recombinant glycosylation-inhibiting factor mutants. J Immunol 162: 195-202, 1999.
141. Ueda S, Masutani H, Nakamura H, Tanaka T, Ueno M, and Yodoi J. Redox control of cell death. Antioxid Redox Signal 4: 405-414, 2002.
142. UhLe S, Medalia O, Waldron R, Dumdey R, Henklein P, Bech-Otschir D, Huang X, Berse M, Sperling J, Schade R, and Dubiel W. Protein kinase CK2 and protein kinase D are associated with the COP9 signalosome. EMBO J 22: 1302-1312, 2003.
143. Verhaegh GW, Richard MJ, and Hainaut P. Regulation of p53 by metal ions and by antioxidants: dithiocarbamate down-regulates p53 DNA-binding activity by increasing the intracellular level of copper. Mol Cell Biol 17: 5699-5706, 1997.
144. Waeber G, Calandra T, Roduit R, Haefliger JA, Bonny C, Thompson N, Thorens B, Temler E, Meinhardt A, Bacher M, Metz CN, Nicod P, and Bucala R. Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor. Proc Natl Acad Sci USA 94: 4782-4787, 1997.
145. Waksman G, Krishna TS, Williams CHJ, and Kuriyan J. Crystal structure of Escherichia coli thioredoxin reductase refined at 2 Å resolution. Implications for a large conformational change during catalysis. J Mol Biol 236: 800-816, 1994.
146. Watarai H, Nozawa R, Tokunaga A, Yuyama N, Tomas M, Hinohara A, Ishizaka K, and Ishii Y. Posttranslational modification of the glycosylation inhibiting factor (GIF) gene product generates bioactive GIF. Proc Natl Acad Sci U S A 91: 13251-13256, 2000.
147. Watson WH, Pohl J, Montfort WR, Stuchlik O, Reed MS, Powis G, and Jones DP. Redox potential of human thioredoxin 1 and identification of a second dithiol/disulfide motif. J Biol Chem 278: 33408-33415, 2003.
148. Wei N and Deng XW. Making sense of the COP9 signalosome. A regulatory protein complex conserved from Arabidopsis to human. Trends Genet 15: 98-103, 1999.
149. Wei N and Deng XW. The COP9 signalosome. Annu Rev Cell Dev Biol 19: 261-286, 2003.
150. Weigand MA, Horner C, Bardenheuer HJ, and Bouchon A. The systemic inflammatory response syndrome. Best Pract Res Clin Anaesthesiol 18: 455-475, 2004.
151. Weiser WY, Temple DM, Witek-Gianotti JS, Remold HG, Clark SC, and David JR. Molecular cloning of cDNA encoding a human macrophage migration inhibition factor. Proc Natl Acad Sci USA 86: 7522-7526, 1989.
152. Wilkinson B and Gilbert HF. Protein disulfide isomerase. Biochim Biophys Acta 1699: 35-44, 2004.
153. Wolf DA, Zhou C, and Wee S. The COP9 signalosome: an assembly and maintenance platform for cullin ubiquitin ligases? Nat Cell Biol 5: 1029-1033, 2003.
154. Zhang R and Snyder GH. Dependence of formation of small disulfide loops in two-cysteine peptides on the number and types of intervening amino acids. J Biol Chem 264: 18472-18479, 1989.